Farnesyltransferase inhibitors as radiation sensitizers.
Activation of Ras, by mutation, overexpression, or by signaling through tyrosine kinase receptors, is associated with radioresistance. Thus, therapies that inhibit Ras function could be an effective means to radiosensitize selected types of solid tumors. Inhibition of Ras prenylation using a variety...
Main Authors: | Mckenna, W, Muschel, R, Gupta, A, Hahn, S, Bernhard, E |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2002
|
Registos relacionados
-
Farnesyltransferase inhibitors as radiation sensitizers.
Por: Brunner, T, et al.
Publicado em: (2003) -
Farnesyltransferase inhibitors as radiation sensitizers
Por: Mckenna, W
Publicado em: (2005) -
Farnesyltransferase inhibitors.
Por: Hahn, S, et al.
Publicado em: (2001) -
Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations.
Por: Brunner, T, et al.
Publicado em: (2003) -
The farnesyltransferase inhibitor L744,832 reduces hypoxia in tumors expressing activated H-ras.
Por: Cohen-Jonathan, E, et al.
Publicado em: (2001)